Excerpt from:
OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank
Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
Saniona Changes Date of Annual Report for 2021
Excerpt from:
Saniona Changes Date of Annual Report for 2021
Vistin Pharma ASA: First quarter 2022 financial results
Continue reading here:
Vistin Pharma ASA: First quarter 2022 financial results
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase
Read more from the original source:
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase
AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia
Total number of shares and voting rights in Zealand Pharma at December 30, 2021
See the original post:
Total number of shares and voting rights in Zealand Pharma at December 30, 2021
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2…
Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022
Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes
Read more from the original source:
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes